Privia Health Group, Inc. (PRVA) Current Ratio
- Current ratio · latest quarter: Value 1.62×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.62× | Current assets / current liabilities. $1.03B ÷ $634.44M ≈ 1.62× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 1.03B USD | Assets, Current |
| Current obligations | 634.44M USD | Liabilities, Current |
| Cash and equivalents | 412.20M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 574.16M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 8.49M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.03B | $634.44M | $412.20M | (m) | $574.16M | (m) | $8.49M | (m) | 1.62× |
| 2026-03-31 | $966.02M | $601.30M | $419.52M | (m) | $513.68M | (m) | $10.65M | (m) | 1.61× |
| 2025-12-31 | $911.00M | $568.52M | $479.69M | (m) | $400.90M | (m) | $7.97M | (m) | 1.60× |
| 2025-09-30 | $970.93M | $582.91M | $441.35M | (m) | $499.04M | (m) | $10.22M | (m) | 1.67× |
| 2025-06-30 | $882.96M | $534.85M | $390.13M | (m) | $443.99M | (m) | $9.01M | (m) | 1.65× |
| 2025-03-31 | $886.47M | $470.81M | $469.33M | (m) | $388.73M | (m) | $7.95M | (m) | 1.88× |
| 2024-12-31 | $834.82M | $449.15M | $491.15M | (m) | $316.18M | (m) | $9.76M | (m) | 1.86× |
| 2024-09-30 | $853.75M | $479.47M | $422.00M | (m) | $408.96M | (m) | $6.93M | (m) | 1.78× |
| 2024-06-30 | $779.67M | $429.59M | $387.35M | (m) | $370.06M | (m) | $9.06M | (m) | 1.81× |
| 2024-03-31 | $728.14M | $403.80M | $351.14M | (m) | $346.09M | (m) | $6.43M | (m) | 1.80× |
| 2023-12-31 | $700.80M | $386.95M | $389.51M | (m) | $290.77M | (m) | $7.88M | (m) | 1.81× |
| 2023-09-30 | $697.67M | $394.19M | $330.39M | (m) | $350.11M | (m) | $7.14M | (m) | 1.77× |
| 2023-06-30 | $654.00M | $358.44M | $317.94M | (m) | $319.84M | (m) | $5.36M | (m) | 1.82× |
| 2023-03-31 | $588.78M | $309.69M | $311.23M | (m) | $260.88M | (m) | $6.95M | (m) | 1.90× |
| 2022-12-31 | $551.96M | $264.27M | $347.99M | (m) | $189.60M | (m) | $6.73M | (m) | 2.09× |
| 2022-09-30 | $579.65M | $304.53M | $316.90M | (m) | $246.35M | (m) | $5.21M | (m) | 1.90× |
| 2022-06-30 | $521.27M | $265.14M | $292.19M | (m) | $213.89M | (m) | $6.52M | (m) | 1.97× |
| 2022-03-31 | $492.56M | $220.35M | $315.93M | (m) | $166.24M | (m) | $8.46M | (m) | 2.24× |
| 2021-12-31 | $446.68M | $190.46M | $320.58M | (m) | $117.40M | (m) | $2.97M | (m) | 2.35× |
| 2021-09-30 | $469.42M | $187.24M | $362.11M | (m) | $98.38M | (m) | $3.27M | (m) | 2.51× |
| 2021-06-30 | $436.45M | $167.32M | $299.75M | (m) | $126.87M | (m) | $4.52M | (m) | 2.61× |
| 2021-03-31 | $204.65M | $157.52M | $81.94M | (m) | $116.72M | (m) | $3.81M | (m) | 1.30× |
| 2020-12-31 | $190.08M | $146.94M | $84.63M | (m) | $99.12M | (m) | $5.24M | (m) | 1.29× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |